Ulyee Choe, DO
Fellowship, Infectious Disease, University of South Florida, Tampa, FL
Residency, Internal Medicine, University of South Florida, Tampa, FL
Rotating Internship, Northside Hospital, St. Petersburg, FL
DO, Nova Southeastern University College of Osteopathic Medicine, Ft. Lauderdale, Fl
Phone: (813) 844-4187
Biographical Sketch
Areas of ExpertiseCurrent Research (Co-Investigator)
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-bosted Atazanavir versus Ritonavir-Boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults.
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 versus Ritonavir-boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults.
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults.
A Phase 2, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS 9137 (GS 9137/r) Administered in Combination with Other Antiretroviral Agents for the Treatment of HIV-1 Infected subjects.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a Novel CCR5 Antagonist, UK-427,857, in Combination with Optimized Background Therapy versus Optimized Background Therapy along for the Treatment of Antiretroviral-Experienced HIV-1 Infected Subjects. [Pfizer A4001027]
A Randomized, Controlled, Partially-Blinded Phase IIb Dose-finding Trial of TMC125 in HIV-1 Infected Subjects with Documented Genotypic Evidence of Resistance to Currently Available NNRTIs and with at Least Three Primary PI Mutations. (TMC125-C223)
A Phase II, Randomized, Blinded, 12-Week Comparison of Elvucitabine in Combination with Efavirenz and Tenofovir versus Lamivudine in Combination with Efavirenz and 4 Tenofovir in HIV-1 Infected, Treatment-Naïve Subjects, with a 12-Week Extension Treatment Period. [ACH443-015]
A Large, Simple Trial Comaring Two Strategies for Management of Anti-Retroviral Therapy. [SMART CPCRA 065]
A Randomized, Controlled, Open-Label Trial to Compare the Efficacy, Safety and Tolerability of TMC114/Ritonavir versus Lopinavir/Ritonavir in Treatment-Naïve HIV-1 Infected Subjects. This trial will be referred to as ARTMEMIS. [TMC114-211]
Publications/Presentations
Choe U, Oller K, Casanas, B. An Unusual Case of Toxoplasmosis Presenting as a Cecal Mass. Awaiting publication.
Choe U, Casanas B. Polymicrobial Bacteremia with Eggerthella lenta and Peptostreptococcus micros Associated with a Lung Abscess. Awaiting publication.Choe U, Nasr G, Shah M, et al. HIV Virologic Outcomes in Associated with Ritonavir-boosted Atazanavir and Concomitant Acid Suppressive Therapy. Poster to be presented at Infectious Disease Society of America, Boston, MA. October 2011. Awarded traveler’s grant.
Carrington M, Choe U, Stanek D, et al. A fatal case of brucellosis misdiagnosed in early stages of B. suis infection in a 46-year-old patient with Marfan syndrome. Poster to be presented at: 64th Brucellosis Research Conference, Buenos Aires, Argentina. September 2011.
Gompf SG, Smith K, Choe U. Arenaviruses. eMedicine at WebMD. 2011. Available online.
Choe U. HPV Vaccine Recommendations. Florida/Caribbean AIDS Education and Training Center HIV Carelink. 2011; 12 (2).
Choe U. HIV Treatment Strategies. Presentation at the HIV Intensive Course at the Southeast STD/HIV Prevention Training Center, Tampa, FL. October 2010.
Choe U. HIV Virologic Outcomes in Associated with Ritonavir-boosted Atazanavir and Concomitant Acid Suppressive Therapy. Presentation at Florida Infectious Disease Society Meeting; Orlando, FL. June 2010.
Franck R, Choe U, Montero J. A case of coccidioidomycosis presenting as military tuberculosis. Poster presented at: The American College of Physicians; Tampa, FL Sept 2007.